APO Research
Talk to an analyst

APO RESEARCH · REPORT

Niraparib

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Niraparib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025176 pages

Choose your research edition.

Industry ResearchNiraparib Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Niraparib Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Niraparib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Niraparib Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Niraparib Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Niraparib market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Niraparib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Niraparib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Niraparib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Niraparib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Niraparib include TESARO and Everest Pharmaceuticals Limited among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Niraparib market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Niraparib and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Niraparib sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Niraparib market size, projected growth trends, production technologies, key applications, and end-use industries.

Niraparib Segment by Company

TESARO

Everest Pharmaceuticals Limited

Niraparib Segment by Type

100mg*30 Capsules

100mg*60 Capsules

100mg*90 Capsules

Niraparib Segment by Application

Primary Peritoneal Cancer

Fallopian Tube Cancer

Recurrent Epithelial Ovarian Cancer

Others

Niraparib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Niraparib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Niraparib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Niraparib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Niraparib market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Niraparib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Niraparib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Niraparib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Niraparib Industry Trends Table 2. Niraparib Industry Drivers Table 3. Niraparib Industry Opportunities and Challenges Table 4. Niraparib Industry Restraints Table 5. Global Niraparib Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Niraparib Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Niraparib Sales by Manufacturers (k pcs) & (2021-2026) Table 8. Global Niraparib Sales Market Share by Manufacturers Table 9. Global Niraparib Average Sales Price (US$/pcs) of Manufacturers (2021-2026) Table 10. Global Niraparib Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Niraparib Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Niraparib Manufacturers, Product Type & Application Table 13. Global Niraparib Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Niraparib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 100mg*30 Capsules Table 17. Major Manufacturers of 100mg*60 Capsules Table 18. Major Manufacturers of 100mg*90 Capsules Table 19. Global Niraparib Sales by Type 2021 VS 2025 VS 2032 (k pcs) Table 20. Global Niraparib Sales by Type (2021-2026) & (k pcs) Table 21. Global Niraparib Sales by Type (2027-2032) & (k pcs) Table 22. Global Niraparib Sales Market Share by Type (2021-2026) Table 23. Global Niraparib Sales Market Share by Type (2027-2032) Table 24. Global Niraparib Revenue by Type 2021 VS 2025 VS 2032 (k pcs) Table 25. Global Niraparib Revenue by Type (2021-2026) & (k pcs) Table 26. Global Niraparib Revenue by Type (2027-2032) & (k pcs) Table 27. Global Niraparib Revenue Market Share by Type (2021-2026) Table 28. Global Niraparib Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Primary Peritoneal Cancer Table 30. Major Manufacturers of Fallopian Tube Cancer Table 31. Major Manufacturers of Recurrent Epithelial Ovarian Cancer Table 32. Major Manufacturers of Others Table 33. Global Niraparib Sales by Application 2021 VS 2025 VS 2032 (k pcs) Table 34. Global Niraparib Sales by Application (2021-2026) & (k pcs) Table 35. Global Niraparib Sales by Application (2027-2032) & (k pcs) Table 36. Global Niraparib Sales Market Share by Application (2021-2026) Table 37. Global Niraparib Sales Market Share by Application (2027-2032) Table 38. Global Niraparib Revenue by Application 2021 VS 2025 VS 2032 (k pcs) Table 39. Global Niraparib Revenue by Application (2021-2026) & (k pcs) Table 40. Global Niraparib Revenue by Application (2027-2032) & (k pcs) Table 41. Global Niraparib Revenue Market Share by Application (2021-2026) Table 42. Global Niraparib Revenue Market Share by Application (2027-2032) Table 43. Global Niraparib Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Table 44. Global Niraparib Sales by Region (2021-2026) & (k pcs) Table 45. Global Niraparib Sales Market Share by Region (2021-2026) Table 46. Global Niraparib Sales Forecasted by Region (2027-2032) & (k pcs) Table 47. Global Niraparib Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Niraparib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k pcs) Table 49. North America Niraparib Sales by Country (2021-2026) & (k pcs) Table 50. North America Niraparib Sales by Country (2027-2032) & (k pcs) Table 51. Europe Niraparib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k pcs) Table 52. Europe Niraparib Sales by Country (2021-2026) & (k pcs) Table 53. Europe Niraparib Sales by Country (2027-2032) & (k pcs) Table 54. Asia Pacific Niraparib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k pcs) Table 55. Asia Pacific Niraparib Sales by Country (2021-2026) & (k pcs) Table 56. Asia Pacific Niraparib Sales by Country (2027-2032) & (k pcs) Table 57. South America, Middle East and Africa Niraparib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k pcs) Table 58. South America, Middle East and Africa Niraparib Sales by Country (2021-2026) & (k pcs) Table 59. South America, Middle East and Africa Niraparib Sales by Country (2027-2032) & (k pcs) Table 60. Global Niraparib Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Niraparib Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Niraparib Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Niraparib Revenue Market Share by Region (2021-2026) Table 64. Global Niraparib Revenue Market Share by Region (2027-2032) Table 65. TESARO Company Information Table 66. TESARO Business Overview Table 67. TESARO Niraparib Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. TESARO Niraparib Product Portfolio Table 69. TESARO Recent Development Table 70. Everest Pharmaceuticals Limited Company Information Table 71. Everest Pharmaceuticals Limited Business Overview Table 72. Everest Pharmaceuticals Limited Niraparib Sales (k pcs), Price (US$/pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Everest Pharmaceuticals Limited Niraparib Product Portfolio Table 74. Everest Pharmaceuticals Limited Recent Development Table 75. Key Raw Materials Table 76. Raw Materials Key Suppliers Table 77. Niraparib Distributors List Table 78. Niraparib Customers List Table 79. Research Programs/Design for This Report Table 80. Authors List of This Report Table 81. Secondary Sources Table 82. Primary Sources List of Figures Figure 1. Niraparib Product Image Figure 2. Global Niraparib Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Niraparib Market Size (2021-2032) & (US$ Million) Figure 4. Global Niraparib Sales (2021-2032) & (k pcs) Figure 5. Global Niraparib Average Price (US$/pcs) & (2021-2032) Figure 6. Global Top 5 and 10 Niraparib Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 100mg*30 Capsules Image Figure 9. 100mg*60 Capsules Image Figure 10. 100mg*90 Capsules Image Figure 11. Global Niraparib Sales by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 12. Global Niraparib Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Niraparib Sales Market Share by Type (2021-2032) Figure 14. Global Niraparib Revenue by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 15. Global Niraparib Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Niraparib Revenue Market Share by Type (2021-2032) Figure 17. Primary Peritoneal Cancer Image Figure 18. Fallopian Tube Cancer Image Figure 19. Recurrent Epithelial Ovarian Cancer Image Figure 20. Others Image Figure 21. Global Niraparib Sales by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 22. Global Niraparib Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Niraparib Sales Market Share by Application (2021-2032) Figure 24. Global Niraparib Revenue by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 25. Global Niraparib Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Niraparib Revenue Market Share by Application (2021-2032) Figure 27. North America Niraparib Sales and Growth Rate (2021-2032) & (k pcs) Figure 28. North America Niraparib Sales Market Share by Country (2021-2032) Figure 29. U.S. Niraparib Sales and Growth Rate (2021-2032) & (k pcs) Figure 30. Canada Niraparib Sales and Growth Rate (2021-2032) & (k pcs) Figure 31. Mexico Niraparib Sales and Growth Rate (2021-2032) & (k pcs) Figure 32. Europe Niraparib Sales and Growth Rate (2021-2032) & (k pcs) Figure 33. Europe Niraparib Sales Market Share by Country (2021-2032) Figure 34. Germany Niraparib Sales and Growth Rate (2021-2032) & (k pcs) Figure 35. France Niraparib Sales and Growth Rate (2021-2032) & (k pcs) Figure 36. U.K. Niraparib Sales and Growth Rate (2021-2032) & (k pcs) Figure 37. Italy Niraparib Sales and Growth Rate (2021-2032) & (k pcs) Figure 38. Netherlands Niraparib Sales and Growth Rate (2021-2032) & (k pcs) Figure 39. Asia Pacific Niraparib Sales and Growth Rate (2021-2032) & (k pcs) Figure 40. Asia Pacific Niraparib Sales Market Share by Country (2021-2032) Figure 41. China Niraparib Sales and Growth Rate (2021-2032) & (k pcs) Figure 42. Japan Niraparib Sales and Growth Rate (2021-2032) & (k pcs) Figure 43. South Korea Niraparib Sales and Growth Rate (2021-2032) & (k pcs) Figure 44. Southeast Asia Niraparib Sales and Growth Rate (2021-2032) & (k pcs) Figure 45. India Niraparib Sales and Growth Rate (2021-2032) & (k pcs) Figure 46. Australia Niraparib Sales and Growth Rate (2021-2032) & (k pcs) Figure 47. South America, Middle East and Africa Niraparib Sales and Growth Rate (2021-2032) & (k pcs) Figure 48. South America, Middle East and Africa Niraparib Sales Market Share by Country (2021-2032) Figure 49. Brazil Niraparib Sales and Growth Rate (2021-2032) & (k pcs) Figure 50. South Africa Niraparib Sales and Growth Rate (2021-2032) & (k pcs) Figure 51. Saudi Arabia Niraparib Sales and Growth Rate (2021-2032) & (k pcs) Figure 52. Turkey Niraparib Sales and Growth Rate (2021-2032) & (k pcs) Figure 53. Argentina Niraparib Sales and Growth Rate (2021-2032) & (k pcs) Figure 54. UAE Niraparib Sales and Growth Rate (2021-2032) & (k pcs) Figure 55. Egypt Niraparib Sales and Growth Rate (2021-2032) & (k pcs) Figure 56. Chile Niraparib Sales and Growth Rate (2021-2032) & (k pcs) Figure 57. Global Niraparib Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Niraparib Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Niraparib Revenue (2021-2032) & (US$ Million) Figure 60. North America Niraparib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Niraparib Revenue (2021-2032) & (US$ Million) Figure 62. Europe Niraparib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Niraparib Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Niraparib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Niraparib Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Niraparib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Niraparib Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Niraparib Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg*30 Capsules
  • 100mg*60 Capsules
  • 100mg*90 Capsules
Applications
  • Primary Peritoneal Cancer
  • Fallopian Tube Cancer
  • Recurrent Epithelial Ovarian Cancer
  • Others
Companies covered
  • TESARO
  • Everest Pharmaceuticals Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Niraparib Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Niraparib Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Niraparib Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Niraparib Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Niraparib Market Dynamics
  1. 2.1 Niraparib Industry Trends
  2. 2.2 Niraparib Industry Drivers
  3. 2.3 Niraparib Industry Opportunities and Challenges
  4. 2.4 Niraparib Industry Restraints
3 Niraparib Market by Manufacturers
  1. 3.1 Global Niraparib Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Niraparib Sales by Manufacturers (2021-2026)
  3. 3.3 Global Niraparib Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Niraparib Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Niraparib Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Niraparib Manufacturers, Product Type & Application
  7. 3.7 Global Niraparib Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Niraparib Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Niraparib Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Niraparib Tier 1, Tier 2, and Tier 3
4 Niraparib Market by Type
  1. 4.1 Niraparib Type Introduction
  2. 4.1.1 100mg*30 Capsules
  3. 4.1.2 100mg*60 Capsules
  4. 4.1.3 100mg*90 Capsules
  5. 4.2 Global Niraparib Sales by Type
  6. 4.2.1 Global Niraparib Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Niraparib Sales by Type (2021-2032)
  8. 4.2.3 Global Niraparib Sales Market Share by Type (2021-2032)
  9. 4.3 Global Niraparib Revenue by Type
  10. 4.3.1 Global Niraparib Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Niraparib Revenue by Type (2021-2032)
  12. 4.3.3 Global Niraparib Revenue Market Share by Type (2021-2032)
5 Niraparib Market by Application
  1. 5.1 Niraparib Application Introduction
  2. 5.1.1 Primary Peritoneal Cancer
  3. 5.1.2 Fallopian Tube Cancer
  4. 5.1.3 Recurrent Epithelial Ovarian Cancer
  5. 5.1.4 Others
  6. 5.2 Global Niraparib Sales by Application
  7. 5.2.1 Global Niraparib Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Niraparib Sales by Application (2021-2032)
  9. 5.2.3 Global Niraparib Sales Market Share by Application (2021-2032)
  10. 5.3 Global Niraparib Revenue by Application
  11. 5.3.1 Global Niraparib Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Niraparib Revenue by Application (2021-2032)
  13. 5.3.3 Global Niraparib Revenue Market Share by Application (2021-2032)
6 Global Niraparib Sales by Region
  1. 6.1 Global Niraparib Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Niraparib Sales by Region (2021-2032)
  3. 6.2.1 Global Niraparib Sales by Region (2021-2026)
  4. 6.2.2 Global Niraparib Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Niraparib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Niraparib Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Niraparib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Niraparib Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Niraparib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Niraparib Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Niraparib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Niraparib Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Niraparib Revenue by Region
  1. 7.1 Global Niraparib Revenue by Region
  2. 7.1.1 Global Niraparib Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Niraparib Revenue by Region (2021-2026)
  4. 7.1.3 Global Niraparib Revenue by Region (2027-2032)
  5. 7.1.4 Global Niraparib Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Niraparib Revenue (2021-2032)
  8. 7.2.2 North America Niraparib Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Niraparib Revenue (2021-2032)
  11. 7.3.2 Europe Niraparib Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Niraparib Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Niraparib Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Niraparib Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Niraparib Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 TESARO
  2. 8.1.1 TESARO Company Information
  3. 8.1.2 TESARO Business Overview
  4. 8.1.3 TESARO Niraparib Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 TESARO Niraparib Product Portfolio
  6. 8.1.5 TESARO Recent Developments
  7. 8.2 Everest Pharmaceuticals Limited
  8. 8.2.1 Everest Pharmaceuticals Limited Company Information
  9. 8.2.2 Everest Pharmaceuticals Limited Business Overview
  10. 8.2.3 Everest Pharmaceuticals Limited Niraparib Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Everest Pharmaceuticals Limited Niraparib Product Portfolio
  12. 8.2.5 Everest Pharmaceuticals Limited Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Niraparib Value Chain Analysis
  2. 9.1.1 Niraparib Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Niraparib Production Mode & Process
  6. 9.2 Niraparib Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Niraparib Distributors
  9. 9.2.3 Niraparib Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst